ZYRTEC

This brand name is authorized in Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, France, Hong Kong, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, South Africa

Active ingredients

The drug ZYRTEC contains one active pharmaceutical ingredient (API):

1
UNII 64O047KTOA - CETIRIZINE HYDROCHLORIDE
 

Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors. In vitro receptor binding studies have shown no measurable affinity for other than Η1-receptors.

 
Read more about Cetirizine

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ZYRTEC Film-coated tablet / Oral drops / Oral solution MPI, Generic Health Sciences Authority (SG)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R06AE07 Cetirizine R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AE Piperazine derivatives
Discover more medicines within R06AE07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 510609601112312, 510609603131314
DE Bundesinstitut für Arzneimittel und Medizinprodukte 00243748, 00257940, 01433215, 01433221, 01433238, 01467852, 03738203, 04394326, 04394332, 04811126, 04811149, 04811155, 04967029, 04967041, 07736394
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 30024-11-11, 30047-11-11, 30058-12-11
EE Ravimiamet 1022858, 1022869, 1026526, 1077825, 1077836, 1077847, 1525014, 1525025, 1525047, 1525058, 1525115, 1525126, 1525171, 1525182, 1525193, 1525205, 1525216, 1525227, 1525238, 1525249, 1525250, 1525261, 1525272, 1525283, 1728637, 1731563, 1731574, 1731585, 1826580, 1828537, 1829897, 1829909
ES Centro de información online de medicamentos de la AEMPS 58481, 60279, 60280, R-1846, R-1846IP, R1846
FR Base de données publique des médicaments 64949486, 65016707
HK Department of Health Drug Office 33733, 40728
JP 医薬品医療機器総合機構 4490020F1020, 4490020F2027, 4490020R1027
LT Valstybinė vaistų kontrolės tarnyba 1003218, 1003219, 1010903, 1010904, 1065605, 1066078, 1069324, 1082128, 1084154, 1085498, 1085687, 1086334, 1088373, 1091412, 1091413
MT Medicines Authority MA030/00901, MA030/00902, PI908/01901A
NL Z-Index G-Standaard, PRK 26298, 38601
NZ Medicines and Medical Devices Safety Authority 6329, 6330
PL Rejestru Produktów Leczniczych 100001901, 100074834, 100074857, 100131970, 100412515, 100454164
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W59369001, W59369002, W59369003
SG Health Sciences Authority 03022P, 08945P, 10796P, 14890P, 15437P
TN Direction de la Pharmacie et du Médicament 9073241
TR İlaç ve Tıbbi Cihaz Kurumu 8699624090041, 8699624570048, 8699624590015
ZA Health Products Regulatory Authority 28/5.7.1/0477, W/5.7.1/148

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.